The binding of anti-SOD2 antibodies with liposomes demonstrates significant potential application value in the treatment of gliomas. This combination not only enhances the targeting of drugs but also improves their delivery efficiency within the tumor microenvironment. Studies have shown that antibodies targeting SOD2 can selectively attach to glioma cells, enabling precise treatment. Through this mechanism, therapeutic drugs can more effectively penetrate tumor cell membranes, increasing treatment efficacy and reducing damage to normal cells.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1985CT | Recombinant Mouse anti-Human SOD2 Monoclonal antibody (2BF) | ELISA, IP | |
VS3-QX1040 | Mouse Anti-SOD2 Recombinant Antibody (clone 4C4-G8-H12) | WB | Mouse IgG2b |
VS3-QX1041 | Mouse Anti-SOD2 Recombinant Antibody (clone 37CT127.5.11.6) | WB, IHC | Mouse IgG1, κ |
VS-0923-FY139 | Recombinant Mouse Anti-SOD2 Antibody (VS-0923-FY139) | ELISA, WB, IHC | Mouse IgG1 |
VS3-WK2198 | Rabbit Anti-SOD2 (acetyl K68) Recombinant Antibody (clone R69-3Z-7) | WB, IHC-P | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY129. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.